M. S. de Souza, Ratto-Kim, S., Chuenarom, W., Schuetz, A., Chantakulkij, S., Nuntapinit, B., Valencia-Micolta, A., Thelian, D., Nitayaphan, S., Pitisuttithum, P., Paris, R. M., Kaewkungwal, J., Michael, N. L., Rerks-Ngarm, S., Mathieson, B., Marovich, M., Currier, J. R., and Kim, J. H.,
“The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.”,
J Immunol, vol. 188, no. 10, pp. 5166-76, 2012.
]